The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

被引:220
作者
Fazekas, F
Barkhof, F
Filippi, M
Grossman, RI
Li, DKB
McDonald, WI
McFarland, HF
Paty, DW
Simon, JH
Wolinsky, JS
Miller, DH
机构
[1] Graz Univ, Dept Neurol, A-8036 Graz, Austria
[2] Graz Univ, MRI Ctr, A-8036 Graz, Austria
[3] Vrije Univ Hosp, Amsterdam, Netherlands
[4] Univ Milan, Dept Neurosci, Neuroimaging Res Unit, Sci Inst Osped San Raffaele, I-20122 Milan, Italy
[5] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[7] Inst Neurol, London WC1N 3BG, England
[8] NIH, Bethesda, MD 20892 USA
[9] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[10] Univ Texas, Sch Med, Houston, TX USA
关键词
D O I
10.1212/WNL.53.3.448
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
MRI is very sensitive in showing MS lesions throughout the CNS, Using MRI for diagnostic purposes, however useful, is a complex issue because of limited specificity of findings and a variety of options as to when, how, and which patients to examine. Comparability of data and a common view regarding the impact of MRI are needed. Following a review of the typical appearance and pattern of MS lesions including differential diagnostic considerations, we suggest economic MRI examination protocols for the brain and spine. Recommendations for referral to MRI consider the need to avoid misdiagnosis and the probability of detecting findings of diagnostic relevance. We also suggest MRI classes of evidence for MS to determine the diagnostic weight of findings and their incorporation into the clinical evaluation. These proposals should help to optimize and standardize the use of MRI in the diagnosis of MS.
引用
收藏
页码:448 / 456
页数:9
相关论文
共 71 条
[1]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[2]   A CORRELATIVE TRIAD OF GADOLINIUM-DTPA MRI, EDSS, AND CSF-MBP IN RELAPSING MULTIPLE-SCLEROSIS PATIENTS TREATED WITH HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE [J].
BARKHOF, F ;
FREQUIN, STFM ;
HOMMES, OR ;
LAMERS, K ;
SCHELTENS, P ;
VANGEEL, WJA ;
VALK, J .
NEUROLOGY, 1992, 42 (01) :63-67
[3]   BRAIN MAGNETIC-RESONANCE-IMAGING IN ACUTE OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS STUDY-GROUP [J].
BECK, RW ;
ARRINGTON, J ;
MURTAGH, FR ;
CLEARY, PA ;
KAUFMAN, DI .
ARCHIVES OF NEUROLOGY, 1993, 50 (08) :841-846
[4]  
CAMPI A, 1995, AM J NEURORADIOL, V16, P115
[5]  
CATALAA I, 1999, IN PRESS AM J NEUROR
[6]   BRAIN MRI CORRELATES OF COGNITIVE IMPAIRMENT IN PRIMARY AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS [J].
COMI, G ;
FILIPPI, M ;
MARTINELLI, V ;
CAMPI, A ;
RODEGHER, M ;
ALBERONI, M ;
SIRABIAN, G ;
CANAL, N .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 132 (02) :222-227
[7]   PATHOLOGICAL CORRELATES OF INCIDENTAL MRI WHITE-MATTER SIGNAL HYPERINTENSITIES [J].
FAZEKAS, F ;
KLEINERT, R ;
OFFENBACHER, H ;
SCHMIDT, R ;
KLEINERT, G ;
PAYER, F ;
RADNER, H ;
LECHNER, H .
NEUROLOGY, 1993, 43 (09) :1683-1689
[8]   CRITERIA FOR AN INCREASED SPECIFICITY OF MRI INTERPRETATION IN ELDERLY SUBJECTS WITH SUSPECTED MULTIPLE-SCLEROSIS [J].
FAZEKAS, F ;
OFFENBACHER, H ;
FUCHS, S ;
SCHMIDT, R ;
NIEDERKORN, K ;
HORNER, S ;
LECHNER, H .
NEUROLOGY, 1988, 38 (12) :1822-1825
[9]   QUANTITATIVE BRAIN MRI LESION LOAD PREDICTS THE COURSE OF CLINICALLY ISOLATED SYNDROMES SUGGESTIVE OF MULTIPLE-SCLEROSIS [J].
FILIPPI, M ;
HORSFIELD, MA ;
MORRISSEY, SP ;
MACMANUS, DG ;
RUDGE, P ;
MCDONALD, WI ;
MILLER, DH .
NEUROLOGY, 1994, 44 (04) :635-641
[10]   Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis [J].
Filippi, M ;
Horsfield, MA ;
Adèr, HJ ;
Barkhof, F ;
Bruzzi, P ;
Evans, A ;
Frank, JA ;
Grossman, RI ;
McFarland, HF ;
Molyneux, P ;
Paty, DW ;
Simon, J ;
Tofts, PS ;
Wolinsky, JS ;
Miller, DH .
ANNALS OF NEUROLOGY, 1998, 43 (04) :499-506